Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II.
Saved in:
| Title: | Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II. |
|---|---|
| Authors: | Tzellos T; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; Department of Dermatology, Nordland Hospital Trust, Bodø, Norway., Giamarellos-Bourboulis EJ; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece., van Straalen KR; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands., Martorell A; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; Department of Dermatology, Hospital de Manises, Valencia, Spain., Kirby B; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; St Vincent's University Hospital, Elm Park and the Charles Institute, University College Dublin, Dublin, Ireland., Alavi A; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; Department of Dermatology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA., Hayama K; Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan., Khattri S; Department of Dermatology, The Mount Sinai Hospital, New York, New York, USA., Gulliver W; Newlab Clinical Research Inc., St John's, Newfoundland and Labrador, Canada., Sayed CJ; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Davis L; UCB, Morrisville, North Carolina, USA., Rolleri RL; UCB, Morrisville, North Carolina, USA., Crater C; UCB, Morrisville, North Carolina, USA., Pansar I; UCB, Brussels, Belgium., Lambert J; UCB, Colombes, France., Zouboulis CC; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; Department of Dermatology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.; Department of Venereology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.; Department of Allergology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.; Department of Immunology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany. |
| Source: | Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2026 Feb 14. Date of Electronic Publication: 2026 Feb 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
